With two decades of experience in intellectual property law, Lisa Hillman's practice encompasses domestic and foreign patent procurement and portfolio management, interference practice, client counseling on validity, infringement, freedom-to-operate, due diligence review and patent strategy matters.

Lisa has broad experience in patent procurement and portfolio management in the areas of molecular biology, microbiology, fermentation technologies, human and veterinary diagnostics, personal diagnostics, proteomics, siRNA technologies, antibody technologies, CRISPR technologies, liposomes, biosensors, tissue scaffolds, agriculture, orthobiologics, medical devices,  immunotherapy, and pharmaceuticals. She represents small and large biotechnology, pharmaceutical and diagnostic companies, as well as university clients and startups.